In this current study, we observed that silibinin can exhibit varied effects on PIK3CA expression at different inhibitory concentrations (Fig. 2B), aligning with the results of Jahanafrooz et al., who documented diverse inhibitory effects of silibinin in breast cancer cells [24]. This evidence concerns the gene PIK3CA and breast carcinoma.